Pharmaceutical industry sponsorship of journal supplements [1]

Chest

Volumn 129, Issue 5, 2006, Pages 1387-

  Kahn, Jeremy M ^a   Coitein, Lara ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

BLOOD TRANSFUSION; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG MARKETING; FUNDING; LETTER; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; RESPIRATORY FAILURE; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; MEDICAL RESEARCH;

BIOMEDICAL RESEARCH; DRUG INDUSTRY; HUMANS; PERIODICALS; RESEARCH SUPPORT;

EID: 33646484195     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.5.1387     Document Type: Letter

References (9)

1. Levy MM. Pathophysiology of oxygen delivery in respiratory failure. Chest 2005; 128:5475-3535
2. Huang YC. Monitoring oxygen delivery in the critically ill. Chest 2005; 128:554S-560S
3. MacIntyre NR. Current issues in mechanical ventilation for respiratory failure. Chest 2005; 128:5618-5678
4. Silver MR. Anemia in the long-term ventilator-dependent patient with respiratory failure. Chest 2005; 128:5685-5758
5. Ouellette DR. The impact of anemia in patients with respiratory failure. Chest 2005; 128:5768-5828
6. Shorr AF, Kollef MH. Ventilator-associated pneumonia: insights from recent clinical trials. Chest 2005; 128:5838-5918
7. Pinsky MR. Cardiovascular issues in respiratory care. Chest 2005; 128:5928-5978
8. Shander A, Popovsky MA. Understanding the consequences of transfusion-related acute lung injury. Chest 2005; 128:598S-604S
9. Silver M, Bazan A, Corwin H. et al. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin in long-term acute care patients [abstract]. Crit Care Med 2003; 31:A145